India Q2 FY27 Earnings Season: Mid-Caps Show Broad Revenue and Margin Gains
India's Q2 FY27 earnings season shows broad mid-cap revenue growth, with several companies posting 28-110% YoY gains
TLDR
- โIndia's Q2 FY27 earnings season shows broad mid-cap revenue growth, with several companies posting 28-110% YoY gains
- โSportking India nearly doubled EBITDA margins to 19.8% while Bharat Parenterals posted 110% revenue growth
- โGK Energy's 39% H1 revenue growth is tempered by 204-day receivables, highlighting collection risk in capex-heavy sectors
Editorial Self-Reviewยท72/100Review tier
- 30-source cluster provides exceptional breadth, strong sector coverage
- Comprehensive India mid-cap earnings signal
- 30 GuruFocus T3 articles โ lower tier, limited earnings detail per company
- No specific EPS figures
Why this matters
Coverage sentiment: Bullish (25 bullish ยท 4 neutral ยท 1 bearish)
This earnings roundup covers Indian mid-cap companies directly. The breadth of Q2 FY27 beats signals robust domestic consumption and infrastructure capex momentum relevant to India-focused equity funds.
What to watch
- โข Q3 FY27 guidance across mid-cap cohort: whether festive-season revenue sustains the 25-110% growth trajectory visible in Q2
- โข India GST October collections update: macro confirmation of domestic demand sustaining earnings-season momentum
Ripple effects
- โข India mid-cap ETFs and funds (Nifty Midcap 150 derivatives) โ bullish as broad earnings beats validate mid-cap re-rating thesis
AI-Synthesized news from multiple sources
This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this ยท Editorial standards ยท Report an error
The Quick Take
- India's Q2 FY27 earnings season shows broad mid-cap revenue growth, with several companies posting 28-110% YoY gains
- Sportking India nearly doubled EBITDA margins to 19.8% while Bharat Parenterals posted 110% revenue growth
- GK Energy's 39% H1 revenue growth is tempered by 204-day receivables, highlighting collection risk in capex-heavy sectors
- Pharma names including Jagsonpal and Piramal show 25-29% revenue growth reflecting strong domestic demand
India's Q2 FY27 earnings season is delivering a consistent picture of broad-based mid-cap revenue expansion, with manufacturing, pharma, and technology services companies posting above-consensus growth. The results reflect the continued momentum of India's domestic consumption cycle and infrastructure push, with greenfield capacity additions โ visible in Sportking's Odisha plant expansion and Bharat Parenterals' production ramp โ translating into earnings leverage. This cycle differs from FY26's patchy recovery: companies with order books and advance payments are converting backlog to revenue more efficiently, and margin expansion is widespread rather than concentrated in just a few sectors.
The breadth of earnings beats across diverse sectors โ renewable energy (GK Energy), textiles (Sportking, Iris Clothings), pharma (Jagsonpal, Bharat Parenterals), and IT services (Sasken Technologies) โ signals that India's cyclical recovery is not AI-narrow or export-dependent. Mid-cap valuations, which had compressed in late FY26 amid concerns about earnings quality, receive a fundamental reset from these results. FII and DII positioning in the mid-cap segment, which lagged the large-cap Nifty recovery in Q3 FY26, is likely to re-engage. However, elevated receivables in capex-intensive sectors like energy (204 days for GK Energy) represent a cash-conversion risk that selectively constrains which names can sustain outperformance.
The forward indicator to watch is whether Q3 FY27 guidance reaffirms the revenue trajectory visible in Q2. Specifically, GK Energy's PM Kusum rollout pace โ a government solar scheme โ and Sasken Technologies' order book conversion will signal whether government-sponsored capex continues to drive mid-cap order flows into Q4. The macro variable is India's domestic consumption demand, measured through festive-season (Oct-Nov) retail sales data. If the festive quarter delivers above-trend demand, Q3 FY27 guidance upgrades are likely across consumer, retail, and logistics names. Any slowdown in GST collections would be the first macro warning signal.
Synthesized from 30 sources.
Market Intelligence Panel
Sentiment
BullishCoverage
livesources covering this story
Live Price
NSE:NIFTY๐ India / Asia Angle
This earnings roundup covers Indian mid-cap companies directly. The breadth of Q2 FY27 beats signals robust domestic consumption and infrastructure capex momentum relevant to India-focused equity funds.
๐ Ripple Effects
- โธIndia mid-cap ETFs and funds (Nifty Midcap 150 derivatives) โ bullish as broad earnings beats validate mid-cap re-rating thesis
- โธIndian banking sector โ credit demand signal from capex-related order books and expansion projects of reporting companies
- โธFIIs with India mid/small-cap exposure โ positive earnings quality data supports continued allocation post-festive-season results
๐ญ What to Watch Next
PRO- โธQ3 FY27 guidance across mid-cap cohort: whether festive-season revenue sustains the 25-110% growth trajectory visible in Q2
- โธIndia GST October collections update: macro confirmation of domestic demand sustaining earnings-season momentum
- โธGK Energy PM Kusum scheme rollout pace in Q3: government-backed capex is the key enabler for infrastructure mid-caps
Market news synthesis. Not financial advice. Sources cited above.
How the Story Spread
30 publishers covering this story
AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.
โ Tier 3 โ Niche & specialist
GK Energy Ltd (NSE:GKENERGY) (Q2 2027) Earnings Call Highlights: 39% H1 Revenue Surge, Rs 1,422 ...
GK Energy Ltd (NSE:GKENERGY) pairs strong H1 FY27 growth and a Rs 788 crore order book with 204-day receivables and a PM Kusum rollout that hinges on Q3 FY27. Related Stocks: NSE:GKENERGY,
Sportking India Ltd (BOM:539221) (Q2 2027) Earnings Call Highlights: Margin Surge, Odisha ...
Sportking India Ltd (BOM:539221) nearly doubled its EBITDA margin to 19.8% in Q2 FY27, with its Odisha greenfield plant set to begin commercial production within 30-40 days. Related Stocks: BOM:539221,
Sasken Technologies Ltd (BOM:532663) (Q2 2027) Earnings Call Highlights: Revenue Surges 25. ...
Sasken Technologies Ltd (BOM:532663) posted strong Software Services growth and a USD 47 million order book, though Product Solutions revenue fell 42% sequentially on memory constraints. Related Stocks: BOM:532663,
Jagsonpal Pharmaceuticals Ltd (BOM:507789) (Q2 2027) Earnings Call Highlights: Revenue Jumps ...
Jagsonpal Pharmaceuticals Ltd (BOM:507789) posted consolidated revenue of INR 96 crore in Q2 FY27, up 29% YoY, with management targeting INR 100 crore in Q3 and INR 500 crore by 2028. Related Stocks: BOM:507789,
Bharat Parenterals Ltd (BOM:541096) (Q2 2027) Earnings Call Highlights: Revenue Doubles, Profit ...
Bharat Parenterals Ltd (BOM:541096) posted 110% revenue growth and a swing back to profit in Q2 FY27, while flagging input-cost pressure in its standalone business and lumpy Inoxel licensing income. Related Stocks: BOM:541096,
Iris Clothings Ltd (NSE:IRISDOREME) (Q2 2027) Earnings Call Highlights: 40% Revenue Surge, ...
Iris Clothings Ltd (NSE:IRISDOREME) posted 40.3% year-on-year total income growth to INR 62.22 crores in Q2 FY27, driven by volume expansion, digital channel ramp-up, and new infant wear capacity. Related Stocks: NSE:IRISDOREME,
R R Kabel Ltd (BOM:543981) (Q2 2027) Earnings Call Highlights: Record H1 Revenue Up 53% and PAT ...
R R Kabel Ltd (BOM:543981) posts its highest-ever half-yearly revenue, EBITDA, and PAT, trims FY27 volume guidance to 14-15%, and targets FMEG breakeven despite a seasonal Q2 setback. Related Stocks: BOM:543981,
Symphony Ltd (BOM:517385) (Q2 2027) Earnings Call Highlights: Revenue Jumps 31% as New Product ...
Symphony Ltd (BOM:517385) posted strong Q2 FY27 growth with EBITDA margin doubling to 13%, while outlining an asset-light entry into room ACs, BLDC fans, and air purifiers. Related Stocks: BOM:517385,
Strides Pharma Science Ltd (BOM:532531) (Q2 2027) Earnings Call Highlights: Ex-US Revenue ...
Strides Pharma Science Ltd (BOM:532531) posted record Q2 FY27 revenue and EBITDA even as gross margins slipped and its $375 million US aspiration was pushed beyond FY28. Related Stocks: BOM:532531,
Sundaram Fasteners Ltd (BOM:500403) (Q2 2027) Earnings Call Highlights: 30% Revenue Surge on ...
Sundaram Fasteners Ltd (BOM:500403) delivered strong Q2 FY27 topline growth driven by exports and OE demand, though steel and aluminum inflation trimmed EBITDA margins to 15.7%. Related Stocks: BOM:500403,
Shaily Engineering Plastics Ltd (BOM:501423) (Q2 2027) Earnings Call Highlights: Record Revenue ...
Shaily Engineering Plastics Ltd (BOM:501423) posted its highest-ever quarterly revenue on the back of GLP-1 pen injector demand, even as consumer segment weakness and pricing pressure linger. Related Stocks: BOM:501423,
Senores Pharmaceuticals Ltd (NSE:SENORES) (Q2 2027) Earnings Call Highlights: Record Revenue ...
Senores Pharmaceuticals Ltd (NSE:SENORES) posts its highest-ever quarterly revenue and EBITDA, with H1 revenue up 30% YoY and a 64-ANDA portfolio nearly doubling year over year. Related Stocks: NSE:SENORES,
Kaveri Seed Co Ltd (BOM:532899) (Q2 2027) Earnings Call Highlights: Q2 Revenue Jumps 30% as New ...
Kaveri Seed Co Ltd (BOM:532899) turned a positive Q2 EBITDA on 29.84% revenue growth, but a 36.3% maize decline dragged H1 revenue down 9.7% and prompted a cautious full-year outlook. Related Stocks: BOM:532899,
Aarti Pharmalabs Ltd (BOM:543748) (Q2 2027) Earnings Call Highlights: Record Revenue of Rs. ...
Aarti Pharmalabs Ltd (BOM:543748) delivered its highest-ever quarterly revenue with 47% YoY growth and an 84% jump in EBITDA, while outlining CDMO expansion and Xanthine capacity ramp-up plans. Related Stocks: BOM:543748,
IIFL Capital Services Ltd (BOM:542773) (Q2 2027) Earnings Call Highlights: Revenue Jumps 22% ...
IIFL Capital Services Ltd (BOM:542773) posted INR722 crore in Q2 FY27 revenue and INR206 crore operational PBT, even as a BSE mark-to-market loss and rising finance costs weighed on results. Related Stocks: BOM:542773,
Ramkrishna Forgings Ltd (BOM:532527) (Q2 2027) Earnings Call Highlights: Revenue Surges 54. ...
Ramkrishna Forgings Ltd (BOM:532527) posted strong Q2 FY27 results with EBITDA margin improving to 18.23%, secured Rs 673 crore in new orders, and expects an even stronger second half. Related Stocks: BOM:532527,
Delhivery Ltd (BOM:543529) (Q2 2027) Earnings Call Highlights: Record Revenue Above INR3,000 ...
Delhivery Ltd (BOM:543529) posted its first-ever quarter with service revenue crossing INR3,000 crores, driven by 225 million Express shipments and new businesses scaling ahead of plan. Related Stocks: BOM:543529,
Ajanta Pharma Ltd (BOM:532331) (Q2 2027) Earnings Call Highlights: Revenue Jumps 33% as US and ...
Ajanta Pharma Ltd (BOM:532331) delivered 33% revenue growth and 49% PAT growth in Q2 FY2027, but management cautioned that US generics and Africa institutional sales will moderate in the second half. Related Stocks: BOM:532331,
Motherson Sumi Wiring India Ltd (BOM:543498) (Q2 2027) Earnings Call Highlights: Revenue Surges ...
Motherson Sumi Wiring India Ltd (BOM:543498) delivered 47% year-on-year revenue growth and 35% PAT growth in Q2 2027, though copper and wage inflation continue to pressure margins. Related Stocks: BOM:543498,
Concord Biotech Ltd (NSE:CONCORDBIO) (Q2 2027) Earnings Call Highlights: 25% Revenue Surge, ...
Concord Biotech Ltd (NSE:CONCORDBIO) posts 25% YoY revenue growth in Q2 FY27 on broad-based API strength, but flags a 400 bps gross margin contraction and underutilized new facilities. Related Stocks: NSE:CONCORDBIO,
Timken India Ltd (BOM:522113) (Q2 2027) Earnings Call Highlights: 25% Revenue Surge, 60% Export ...
Timken India Ltd (BOM:522113) delivered strong Q2 FY27 results with revenue up 25.4% YoY to INR 969 crore and PAT up 29.7%, while navigating input cost inflation and rail tender delays. Related Stocks: BOM:522113,
P N Gadgil Jewellers Ltd (BOM:544256) (Q2 2027) Earnings Call Highlights: 22% Revenue Growth, ...
P N Gadgil Jewellers Ltd (BOM:544256) posted 22% YoY revenue growth to Rs 2,666 crores with EBITDA up 57%, as it accelerates store expansion and targets Rs 17,000 crore-plus revenue by FY29. Related Stocks: BOM:544256,
Aditya Vision Ltd (BOM:540205) (Q2 2027) Earnings Call Highlights: Record Q2 Revenue, 45% PAT ...
Aditya Vision Ltd (BOM:540205) posted its best-ever Q2 with revenue up 28% to Rs 586 crore and PAT up 45% YoY, even as management flagged slow October demand and margin moderation ahead. Related Stocks: BOM:540205,
V-Guard Industries Ltd (BOM:532953) (Q2 2027) Earnings Call Highlights: 71% PAT Surge, ...
V-Guard Industries Ltd (BOM:532953) posted 71% YoY consolidated PAT growth in Q2 FY27 on strong segment revenue, though gross margin slipped to 34% on input cost pressures and a 3-4% pricing gap. Related Stocks: BOM:532953,
Varun Beverages Ltd (NSE:VBL) (Q3 2026) Earnings Call Highlights: 33% Revenue Surge, Africa ...
Varun Beverages Ltd (NSE:VBL) delivered strong 33.2% revenue growth and 28.7% volume gains in Q3 CY2026, but higher packaging costs and Twizza-related expenses weighed on margins and profit growth. Related Stocks: NSE:VBL,
Dodla Dairy Ltd (BOM:543306) (Q2 2027) Earnings Call Highlights: Revenue Jumps 17. ...
Dodla Dairy Ltd (BOM:543306) posted INR1,196 crore revenue and record Africa sales in Q2 FY27, while management guided EBITDA margins to recover to 7.5%-8% in Q3 after a September price hike. Related Stocks: BOM:543306,
Firstsource Solutions Ltd (BOM:532809) (Q2 2027) Earnings Call Highlights: Revenue Jumps 22. ...
Firstsource Solutions Ltd (BOM:532809) posted 22.2% YoY revenue growth with EBIT margin at 12.5%, added 17 new logos, and lifted the lower end of its FY27 constant currency guidance to 10.5%--13%. Related Stocks: BOM:532809,
Gravita India Ltd (BOM:533282) (Q2 2027) Earnings Call Highlights: Revenue Jumps 38% as ...
Gravita India Ltd (BOM:533282) posted strong Q2 FY'27 top-line growth and reaffirmed its INR1,680 crore CapEx plan, even as lead volumes dipped and copper utilization lagged at 50%. Related Stocks: BOM:533282,
Restaurant Brands Asia Ltd (BOM:543248) (Q2 2027) Earnings Call Highlights: 20% Revenue Surge, ...
Restaurant Brands Asia Ltd (BOM:543248) posts 20% revenue growth and 281% EBITDA jump in Q2 2027, but stagnant restaurant margins and Indonesia's Popeyes drag keep investors watching. Related Stocks: BOM:543248,
Piramal Pharma Ltd (BOM:543635) (Q2 2027) Earnings Call Highlights: 28% Revenue Surge, 72% ...
Piramal Pharma Ltd (BOM:543635) delivered broad-based growth across CDMO, Complex Hospital Generics and Consumer Healthcare, prompting management to raise full-year revenue growth guidance to 19%-20%. Related Stocks: BOM:543635,
Get the Daily Briefing
Pre-market analysis every morning at 6am ET. Free.
Was this article useful?
Anonymous ยท helps us tune the editorial system
More ๐ฎ๐ณ India Stories
Zen Technologies Q2 FY27 Profit Surges 51%, Revenue Nearly Doubles on Defense Orders
Zen Technologies reported Q2 FY27 net profit rising 51% to โน89.5 crore on strong defense simulation and training contracts
Nov 1, 2026
๐ฎ๐ณ IndiaIndia Gold Loans Surge 83% to โน5.77 Lakh Crore, Raising Systemic Risk Questions
Outstanding gold loans from Indian banks grew 83% year-on-year to โน5.77 lakh crore, with โน3 lakh crore added recently
Nov 1, 2026
๐ฎ๐ณ IndiaUnregulated India Domestic Airfares Surge Over 450% on Peak Routes
Domestic Indian airfares on some peak routes have surged over 450% amid a lack of government regulation on ticket pricing
Nov 1, 2026